<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-4157</journal-id>
<journal-title><![CDATA[Biomédica]]></journal-title>
<abbrev-journal-title><![CDATA[Biomédica]]></abbrev-journal-title>
<issn>0120-4157</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-41572004000100012</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Differentiation of an adult neuron cell line increases susceptibility to rabies infection]]></article-title>
<article-title xml:lang="en"><![CDATA[Diferentiation of an adult neuron cell line increases susceptibility to rabies infection]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutierrez]]></surname>
<given-names><![CDATA[Marlén Martínez]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barrera]]></surname>
<given-names><![CDATA[Gladys A]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aponte]]></surname>
<given-names><![CDATA[Samanda L]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Baquero]]></surname>
<given-names><![CDATA[Johanna]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Beltrán]]></surname>
<given-names><![CDATA[Magda Y]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[Esperanza Recio]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jaramillo]]></surname>
<given-names><![CDATA[Antonio C]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[Jaime E]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Nacional de Salud Laboratorio de Neurociencias ]]></institution>
<addr-line><![CDATA[Bogotá, D.C. ]]></addr-line>
<country>Colombia.</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidad El Bosque Instituto de Virología ]]></institution>
<addr-line><![CDATA[Bogotá, D.C ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A03">
<institution><![CDATA[,New York School of Medicine Anesthesiology Department ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2004</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>97</fpage>
<lpage>103</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-41572004000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-41572004000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-41572004000100012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Una gran variedad de modelos in vitro se usan para estudiar la infección por virus de rabia, pero hasta el momento no se dispone de una línea neuronal adulta del sistema nervioso central (SNC) para dichos estudios. Por esta razón, nuestro objetivo fue determinar la susceptibilidad de una línea neuronal adulta del SNC (CAD-R1) a la infección por virus de rabia. Para ello, los cultivos se mantuvieron por 5 días en medio con suero (células CAD-R1 indiferenciadas) o sin suero (células CAD-R1 diferenciadas). Luego, se infectaron con una cepa de virus de rabia altamente neurotrópica (CVS) mantenida en células de tipo fibroblástico (CVS-BHK) o en cerebro de ratón (CVS-CR). Los dos tipos de células (indiferenciadas y diferenciadas) se infectaron con ambas cepas de virus de rabia; la proporción de células infectadas en los cultivos diferenciados fue mucho mayor (porcentajes de infección de 83,2% y 78,7% para CVS-BHK y CVS-CR, respectivamente) que en las células indiferenciadas (51,4% y 60,4%) (prueba t de Student<0,05). Estos datos indican que la susceptibilidad a la infección es dependiente del estado de diferenciación celular, posiblemente debido a que estas células adquieren características morfológicas y bioquímicas durante el proceso de diferenciación, que las hace más susceptibles a la infección por el virus de rabia. Con estos resultados, se puede concluir que las células CAD R1 son un buen modelo de infección para el virus de rabia, lo que las convierte en una excelente herramienta para estudiar el neurotropismo del virus de rabia, la patogenia de la infección, el aislamiento de virus o la producción de vacunas más seguras y potentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[A wide variety of in vitro models have been used for studying rabies infection, however, currently, no central nervous system (CNS) adult neuron cultures are available. The current study determined the susceptibility to rabies infection in an adult CNS neuron cell line (CAD-R1). Cultures of CAD-R1 cells were held for 5 days in medium containing serum (undifferentiated CAD-R1 cells) or in serum-free medium (differentiated CAD-R1 cells). They were then infected with highly neurotropic rabies virus (RV) strain (CVS), obtained from fibroblastic cells (CVSBHK) or from adult mouse brain (CVS-MB). Undifferentiated and differentiated cells were infected with the two RV strains, but the percentage of infected cells in differentiated cultures was significantly greater (83% and 79%, respectively) than in undifferentiated cells (51% and 60%) (Student’s t test<0.05). Susceptibility to infection apparently depended on cellular differentiation state, possibly due to acquisition of additional morphological and biochemical characteristics during the differentiation process that made them more susceptible to RV infection. Therefore, CAD R1 cells may represent a good model for RV infection, making them a useful tool for studying RV neurotropism, infection pathogeny, isolation of street virus or producing safer and most potent vaccines.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[virus de rabia]]></kwd>
<kwd lng="es"><![CDATA[cultivo celular]]></kwd>
<kwd lng="es"><![CDATA[líneas neuronales]]></kwd>
<kwd lng="es"><![CDATA[inmunocitoquímica]]></kwd>
<kwd lng="en"><![CDATA[rabies virus]]></kwd>
<kwd lng="en"><![CDATA[cell culture]]></kwd>
<kwd lng="en"><![CDATA[neuronal cell line]]></kwd>
<kwd lng="en"><![CDATA[Immunocytochemistry]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[   <B><FONT FACE="Arial,Arial" SIZE=4>    <P ALIGN="CENTER">Differentiation of an adult neuron cell line</P>     <P ALIGN="CENTER">increases susceptibility to rabies infection</P> </B></FONT><FONT FACE="Arial,Arial">    <P ALIGN="CENTER">Marl&eacute;n Mart&iacute;nez-Gutierrez <SUP>1,2</SUP>, Gladys A. Barrera <SUP>2</SUP>, Samanda L. Aponte <SUP>1,2</SUP>, Johanna Baquero <SUP>1</SUP>,</P>     <P ALIGN="CENTER">Magda Y. Beltr&aacute;n <SUP>1</SUP>, Esperanza Recio-Pinto <SUP>3</SUP>, Antonio C. Jaramillo <SUP>2</SUP>, Jaime E. Castellanos<SUP>1,2</P>     <P>1</SUP> Laboratorio de Neurociencias, Instituto Nacional de Salud, Bogot&aacute;, D.C., Colombia.</P> <SUP>    <P>2</SUP> Instituto de Virolog&iacute;a, Universidad El Bosque, Bogot&aacute;, D.C., Colombia.</P> <SUP>    <P>3</SUP> Anesthesiology Department, New York School of Medicine, New York, USA.</P>     <P>Una gran variedad de modelos <I>in vitro</I> se usan para estudiar la infecci&oacute;n por virus de rabia, pero hasta el momento no se dispone de una l&iacute;nea neuronal adulta del sistema nervioso central (SNC) para dichos estudios. Por esta raz&oacute;n, nuestro objetivo fue determinar la susceptibilidad de una l&iacute;nea neuronal adulta del SNC (CAD-R1) a la infecci&oacute;n por virus de rabia. Para ello, los cultivos se mantuvieron por 5 d&iacute;as en medio con suero (c&eacute;lulas CAD-R1 indiferenciadas) o sin suero (c&eacute;lulas CAD-R1 diferenciadas). Luego, se infectaron con una cepa de virus de rabia altamente neurotr&oacute;pica (CVS) mantenida en c&eacute;lulas de tipo fibrobl&aacute;stico (CVS-BHK) o en cerebro de rat&oacute;n (CVS-CR). Los dos tipos de c&eacute;lulas (indiferenciadas y diferenciadas) se infectaron con ambas cepas de virus de rabia; la proporci&oacute;n de c&eacute;lulas infectadas en los cultivos diferenciados fue mucho mayor (porcentajes de infecci&oacute;n de 83,2% y 78,7% para CVS-BHK y CVS-CR, respectivamente) que en las c&eacute;lulas indiferenciadas (51,4% y 60,4%) (prueba t de Student&lt;0,05). Estos datos indican que la susceptibilidad a la infecci&oacute;n es dependiente del estado de diferenciaci&oacute;n celular, posiblemente debido a que estas c&eacute;lulas adquieren caracter&iacute;sticas morfol&oacute;gicas y bioqu&iacute;micas durante el proceso de diferenciaci&oacute;n, que las hace m&aacute;s susceptibles a la infecci&oacute;n por el virus de rabia. Con estos resultados, se puede concluir que las c&eacute;lulas CAD R1 son un buen modelo de infecci&oacute;n para el virus de rabia, lo que las convierte en una excelente herramienta para estudiar el neurotropismo del virus de rabia, la patogenia de la infecci&oacute;n, el aislamiento de virus o la producci&oacute;n de vacunas m&aacute;s seguras y potentes.</P> <B>    <P>Palabras clave: </B>virus de rabia, cultivo celular, l&iacute;neas neuronales, inmunocitoqu&iacute;mica</P> <B>    ]]></body>
<body><![CDATA[<P>Diffrentiation of an adult neuron cell line increases susceptibility to rabies infection</P> </B>    <P>A wide variety of <I>in vitro</I> models have been used for studying rabies infection, however, currently, no central nervous system (CNS) adult neuron cultures are available. The current study determined the susceptibility to rabies infection in an adult CNS neuron cell line (CAD-R1). Cultures of CAD-R1 cells were held for 5 days in medium containing serum (undifferentiated CAD-R1 cells) or in serum-free medium (differentiated CAD-R1 cells). They were then infected with highly neurotropic rabies virus (RV) strain (CVS), obtained from fibroblastic cells (CVSBHK) or from adult mouse brain (CVS-MB). Undifferentiated and differentiated cells were infected with the two RV strains, but the percentage of infected cells in differentiated cultures was significantly greater (83% and 79%, respectively) than in undifferentiated cells (51% and 60%) (Student’s t test&lt;0.05). Susceptibility to infection apparently depended on cellular differentiation state, possibly due to acquisition of additional morphological and biochemical characteristics during the differentiation process that made them more susceptible to RV infection. Therefore, CAD R1 cells may represent a good model for RV infection, making them a useful tool for studying RV neurotropism, infection pathogeny, isolation of street virus or producing safer and most potent vaccines.</P> <B>    <P>Key words: </B>rabies virus, cell culture, neuronal cell line, Immunocytochemistry</P>     <P>Rabies virus is a highly neurotropic virus, that infects mainly mammal central nervous system (CNS), producing lethal encephalitis (1). Marked neurotropism of rabies virus could be partly explained by the presence of molecules in the neuron membrane which could be acting as viral receptors (2). Recent rabies virus infection pathogeny studies have been mainly focused on the search for such molecules possibly explaining neurotropism and participating in promoting infection (3). Three proteins have been postulated as putative receptors for rabies virus to date: nicotinic acetylcholine receptor (NAChR) (4), neural cell adhesion molecule (NCAM) (5) and low affinity neurotrophin receptor (p75<SUP>NTR</SUP>) (6).</P>     <P>A great variety of <I>in vitro</I> models for both CNS and peripheral nervous systems (PNS) have been used for studying rabies virus infection, including primary dorsal root ganglia cultures (7) or brain neurons (8, 9) and diverse cell lines (10,6,11). The main disadvantage regarding primary cultures is non-neuronal cell presence, making it difficult to study the virus interaction with neurons and the need to supplement them with exogenous neurotrophic factors for neuron survival and maintenance, which could affect RV replication (12). On the other hand, the most frequently used cell lines in virus experiments are non-neuronal and those which are neuronal are embryonic, behaving differently to adult neurons (13). There is currently no CNS adult neuron culture model available for studying RV infection.</P>     <P>Rabies virus presents strict neurotropism <I>in vivo</I>, but it can also infect non-neuronal cells <I>in vitro</I>. It is well known that the fixed Challenge Virus Standard CVS) rabies virus strain preferentially infectsa certain type of cells depending on the type ofcells in which they have been adapted (13,14). If ithas been maintained in adult mouse brain (CVSMB)it becomes more pathogenic and neurotropicthan if it has been adapted to fibroblastic cells(CVS-BHK), in which case (in spite of continuingto be neurotropic) infecting a greater percentageof non-neuronal cells in primary cultures (14,15).</P>     <P>A CNS neuron cell line (called CAD) has recently been isolated (16), this being a variant of the CATH</FONT><FONT FACE=Symbol>a</FONT><FONT FACE="Arial,Arial"> catecolaminergic cell line (obtained by direct tumorogenesis in adult mouse <I>locus coeruleus</I>) (17). Both cell lines express biochemical neuron markers (synaptophisin 38 and neurofilament) and show neuronal physiological characteristics (voltage-dependent sodium and calcium currents) (18,19). Additionally, CAD cells express other biochemical markers such as b-tubulin III, GAP-43 and sinaptotagmin 65 with stronger intensity (16,20). The main characteristic of CAD is that it acquires neuronal morphological features when it is cultured in serum-free medium. CAD-R1 cells represent a subclone derived from CAD, characterized by 98% of the cells having rounded morphology and all cells becoming differentiated following culture in serum-free medium (19). It can be said that this neuronal cell line is the only one reported to date having adult neuron morphological, biochemical and physiological characteristics expressed on being cultured in serumfree medium.</P>     <P>In spite of vaccination against rabies having been developed a century ago, this disease continues to be considered zoonotic and mortal in many countries, its main reservoirs being wild animals (21). The search is thus being continued to find out more about the infection pathogeny, proposing improved models for isolating wild type virus and producing new, safer and more powerful vaccines than the existing ones (22). Bearing in mind that there is no CNS adult neuronal line currently available for studies into RV neurotropism (as a possible improved substrate for isolating the virus and its possible use in producing vaccines), the aim of this work was to determine the CAD-R1 susceptibility to rabies infection, in its two states of differentiation, by two variants of a fixed RV strain (CVS-BHK and CVS-MB).</P> <B>    <P>Materials and methods</P> </B>    <P>CAD-R1 cell cultures</P>     ]]></body>
<body><![CDATA[<P>CAD cells were kindly provided by D. Chikaraishi and J. Wang. CAD R1 subclone was obtained by Recio-Pinto and coworkers (18) and cultured in DMEM/F-12 with 8% foetal bovine serum (FBS, Hyclone) (maintenance medium, MM), 100 U/ml penicillin and 0.1 mg/ml streptomycin also being added. They were kept in 25 cm<SUP>2</SUP> culture flasks until reaching 80% confluence and then were subcultured and seeded in 24-well plastic dishes, on glass coverslips (treated with 10 µg/ml poly-Llysine) at 1,000 and 2,000 cells per well density for CAD-R1 undifferentiated and differentiated cells, respectively. The medium was changed for the first time 24 hours after cells were seeded; one part of the cells was kept undifferentiated using MM and the other part was differentiated by replacing MM with serum free differentiation medium (DM) and adding apotransferrin (20 ng/ml) and sodium selenite (50 ng/ml). The medium was changed each 48 hours up to the fifth day. </P>     <P>Virus and culture infection </P>     <P>Virus variants have already been described (14). CVS-11 adapted to mouse neonatal brain (donated to the Colombian NIH by PAHO/WHO) was used to produce two different virus strains: BHK-21 adapted CVS (CVS-BHK) and adult ICR mouse brain-adapted CVS (CVS-MB) at 10<SUP>5.3 </SUP>and 10<SUP>7.2 </SUP>LD<SUB>50</SUB> titres, respectively. The virus produced was titrated by calculating the LD<SUB>50</SUB> (lethal dose 50) following intracerebral injections of increasing dilutions in young ICR mice (14-16). Viral dilutions were prepared in appropriated medium (MM or MD) from stocks of CVS-BHK and CVS-MB strain. CAD-R1 cells were infected for 1 hour on the fifth day of cell culture, washed and incubated for 24 hours at 37°C with fresh medium to allow viral replication.</P>     <P>Immunocytochemistry for rabies virus</P>     <P>Cultures were fixed on the sixth day with 4% paraformaldehyde. They were then permeabilized with 0.1% Triton X-100 followed by endogenous peroxidase quenching (0.5% H<SUB>2</SUB>O<SUB>2</SUB> in 50% methanol) and blocking unspecific sites (PBS plus 10% neonatal calf serum, NCS). Primary antirabies virus antibody (BioRad 72114C, 1/1000 dilution) was prepared in 5% NCS and incubated for 1 hour at 37°C. Secondary biotinylated antirabbit IgG was similarly prepared in 5% NCS and incubated at room temperature for 30 minutes, followed by Avidin-Biotinylated peroxidase complex (Vector Ltd.) for 30 minutes. Coverslips were revealed with 0.1% 3,3’ diaminobenzidine tetrahydrocloride in Tris-HCl pH 7.2 and 0.02% H<SUB>2</SUB>O<SUB>2</SUB>. They were later counterstained with Mayer’s Hemalum and dehydrated with ascending alcohol concentrations and xylene. Coverslips were mounted with Permount&acirc;. Mock infected cultures were processed as negative controls.</P>     <P>Quantitative and statistical analysis</P>     <P>Two cultures were done with 4 replications for each one (n=8), for each type cell which was infected with the two strains of the virus. Between 3,000 and 10,000 total neurons were counted (infected and non-infected) in ten random fields to obtain infection proportions, later subjected to angular transformation, Student’s t test was used for statistical analysis (p&lt;0.05) to compare undifferentiated and differentiated cells infected with each type of virus (CVS-BHK and CVS-MB).</P> <B>    <P>Results</P> </B>    <P>Morphology of cultures in phase contrast microscopy</P>     <P>Most undifferentiated cells had highly bright rounded soma; however, it is common to find some amorphous and opaque cells in culture (</FONT><A HREF="#figure1"><FONT FACE="Arial,Arial">figure 1A</FONT></A><FONT FACE="Arial,Arial">).Differentiated cells were characterised by presenting neuritic prolongations which were twice the diameter of their soma (</FONT><A HREF="#figure1"><FONT FACE="Arial,Arial">figure 1B</FONT></A><FONT FACE="Arial,Arial">). No apparent morphological differences were observed between infected and non-infected cultures.</P>     ]]></body>
<body><![CDATA[<P><A NAME="figure1"></A></P> </FONT>    <P ALIGN="CENTER"><IMG SRC="/img/revistas/bio/v24n1/1a12i1.jpg"></P> <FONT FACE="Arial,Arial">    <P>Immunocytochemistry</P>     <P>The indirect peroxidase immunodetection technique showed immunoreactivity for rabies virus in vesicles located in the soma of both types of cells (</FONT><A HREF="#figure2"><FONT FACE="Arial,Arial">figures 2A</FONT></A><FONT FACE="Arial,Arial">-B and 2D-E); intense staining in neuritic prolongations was also found in differentiated cells (</FONT><A HREF="#figure2"><FONT FACE="Arial,Arial">figures 2</FONT></A><FONT FACE="Arial,Arial">D and E). Non-infected and processed cultures and those infected cultures to which no anti-rabies antibodies were added used as negative controls did not show reactivity (</FONT><A HREF="#figure2"><FONT FACE="Arial,Arial">figures 2</FONT></A><FONT FACE="Arial,Arial">C and F). Percentage of infected cells is apparently greater in differentiated cells than in undifferentiated ones with whichever of the two viral strains.</P>     <P><A NAME="figure2"></A></P>  </FONT>    <P ALIGN="CENTER"><IMG SRC="/img/revistas/bio/v24n1/1a12i2.jpg"></P> <FONT FACE="Arial,Arial">    <P>Infection percentages </P>     <P>Comparing infection with the two variants of virus used (CVS-BHK or CVS-MB) in undifferentiated and differentiated CAD-R1 cell cultures, it was found that the infection percentages were significantly greater in differentiated cells than in the undifferentiated ones for both viruses (p&lt;0.05). Infection percentages with CVS-BHK were 83.2% in differentiated cells and 51.4% in undifferentiated cells (</FONT><A HREF="#figure3"><FONT FACE="Arial,Arial">figure 3</FONT></A><FONT FACE="Arial,Arial">A). The same happened with CVSMB infection, as the percentage of infected differentiated cells was 78.7% and that for undifferentiated cells was 60.6% (</FONT><A HREF="#figure3"><FONT FACE="Arial,Arial">figure 3</FONT></A><FONT FACE="Arial,Arial">B). No significant differences were found on comparing infection percentages produced by the same viral strain in differentiated or undifferentiated cells.</P> <B>    <P><A NAME="figure3"></A></P>     <P>&nbsp;</P> </B></FONT>    ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><IMG SRC="/img/revistas/bio/v24n1/1a12g1.jpg"></P> <B><FONT FACE="Arial,Arial">    <P>Discussion</P> </B>    <P>When CAD-R1 cells were cultured in MM (with FBS) they continued to proliferate; more than 95% of the population had rounded and bright morphology, however, some amorphous and opaque cells were also found as previously (19). Twenty four hours after being changed to MD (serum-free medium), cells lessened their proliferation and began to acquire a differentiated phenotype, reaching their greatest degree of differentiation after 96 hours. Such differentiation was reversible as adding FBS induces neurite retraction and proliferation begins again. The fact that CAD-R1 cells could stay alive in serum-free medium was due to their ability to produce autocrine or paracrine neurotrophin-3 (20).</P>     <P>It has been considered that these cells become completely differentiated (morphological, biochemical and physiologically) 96 hours after being cultured in serum-free medium (16); infection was thus begun on the fifth day after beginning the culture. No morphological damage or cytolytic effect was observed in cells 24 hours post-infection with CVS rabies virus strain, agreeing with previous data in which it has been proposed that highly neurotropic strains do not cause neuron death (13).</P>     <P>Comparing the percentages of undifferentiated and differentiated cells infected with each one of the viral strains, it was found that both strains infected a greater percentage of differentiated cells (p&lt;0.05), ratifying their <I>in vitro</I> neurotropism. This greater percentage of infection in differentiated cell cultures is possibly because differentiated CAD-R1 cells acquire morphological and biochemical characteristics which they do not possess in their undifferentiated state (16). Moreover the cell differentiation could change enzymatic machinery involved in viral replication. Preliminary results from our group indicate that the three molecules postulated as rabies virus receptors (p75NTR, NCAM and NAChR) are found on CAD-R1 cells, but cell number and staining intensity is greater in differentiated cells (23). In spite of it being known that the rabies virus CVS strain acquires different genotypical and phenotypical characteristics, depending on substrate in which it is maintained (13,14), no infection differences between CVS-BHK and CVS-MB strains were found in the present study.</P>     <P>Even though vaccination against rabies was developed more than a century ago, the disease continues to be considered as being a public health problem in underdeveloped countries (21,22). Control of rabies is based on several activities including animal massive vaccination, development of more potent and safer vaccines (24), establishing more sensitive and economic diagnostic techniques (25) and studying new drugs allowing the infection to be treated once it reaches CNS (26). Neuronal cell lines (such as CAD-R1) having high susceptibility to infection by rabies virus will thus facilitate viral cycle basic research and how to interrupt it, as they can be used as substrate for virus isolation (replacing the mouse inoculation test) or to test experimental sera or drugs.</P>     <P>If these cells are also considered for producing vaccines, the fact of being able to culture them in serum-free medium favours cost and avoids biological safety problems associated with use of cell lines cultured with FBS (27). We are thus dealing with a biological model having ideal characteristics, as culture conditions and cell susceptibility to infection can be controlled, opening infinite possibilities for practical use of this cell line.</P> <B>    <P>Conclusion</P> </B>    <P>CAD-R1 cells are susceptible to being infected by rabies virus; both differentiated and undifferentiated cells were infected in percentages greater than 50%. Differentiation state affected infection percentage, as differentiated cells became infected in greater percentages than undifferentiated ones, possibly indicating biochemical changes favouring virus adsorption or replication. The characterization of this cell line will allow their future use in basic research regarding virus-neuron interaction, testing new antiviral agents and even their use as substrate for producing safer virus vaccine.</P> <B>    <P>Acknowledgements</P> </B>    ]]></body>
<body><![CDATA[<P>The authors thank to Dona Chikaraishi and James Wang for kindly providing the CAD cells used in this study.</P>     <P>Correspondencia:</P>     <P>Marl&eacute;n Mart&iacute;nez, Instituto de Virolog&iacute;a, Universidad El Bosque, Transversal 9A No. 132-55, Laboratorio 205, Bogot&aacute;, D.C., Colombia.</P>     <P>Tel&eacute;fono: (571) 633 1368, extensiones 209 y 272; fax:</P>     <P>(571) 625 2030.</P> </FONT>    <P><A HREF="mailto:martinezmarlen@unbosque.edu.co">martinezmarlen@unbosque.edu.co</A></P> <FONT FACE="Arial,Arial">    <P>Recibido: 24/04/03; aceptado: 31/01/04</P> <B>    <P>References</P> </B>    <!-- ref --><P>1. <B>Rupprecht C, Hanlon CA, Hemachudha T. </B>Rabies re-examined. Lancet Infect Dis 2002;2:327-43.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000061&pid=S0120-4157200400010001200001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>2. <B>Castellanos JE, Hurtado H. </B>Receptores para virus de rabia. Biom&eacute;dica 2001;21:389-401.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000062&pid=S0120-4157200400010001200002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>3. <B>Schweighardt B, Atwood WJ. </B>Virus receptors in the human central nervous system. J Neurovirol 2001;7: 187-95.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000063&pid=S0120-4157200400010001200003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>4. <B>Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. </B>Is the acetylcholine receptor a rabies virus receptor? Science 1982;215:182-4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000064&pid=S0120-4157200400010001200004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>5. <B>Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M. </B>The neural cell adhesion molecule is a receptor for rabies virus. J Virol 1998;72: 7181-90.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000065&pid=S0120-4157200400010001200005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>6. <B>Tuffereau C, Benejean J, Blondel D, Kieffer B, Flammand A. </B>Low-affinity nerve growth factor receptor (p75NTR) can serve as a receptor for rabies virus. EMBO J 1998;17:7250-9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000066&pid=S0120-4157200400010001200006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>7. <B>Castellanos JE, Hurtado H, Arias J, Velandia A. </B>Rabies virus infection of cultured adult mouse dorsal root ganglion neurons. Mem Inst Oswaldo Cruz 1996;91: 621-5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000067&pid=S0120-4157200400010001200007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>8. <B>Ray NB, Power C, Lynch WP, Ewalt LC, Lodmell DL. </B>Rabies viruses infect primary cultures of murine, feline, and human microglia and astrocytes. Arch Virol 1997;142:1011-9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000068&pid=S0120-4157200400010001200008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>9. <B>Guigoni C, Coulon P. </B>Rabies virus is not cytolytic for rat spinal motoneurons in vitro. J Neurovirol 2002;8:306- 17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000069&pid=S0120-4157200400010001200009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>10. <B>Nogueira YL. </B>Morphometric analysis of McCoy cells inoculated with cerebrospinal fluid from patients with rabies. Mem Inst Oswaldo Cruz 1998;93:509-14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000070&pid=S0120-4157200400010001200010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><P>11. <B>Kissi B, Badrane H, Audry L, Lavenu A, Tordo N, Brahimi M, Bourhy. </B>Dynamics of rabies virus quasispecies during serial passages in heterologous hosts. J Gen Virol 1999;80:2041-50.</P>     <!-- ref --><P>12. <B>Castellanos JE, Mart&iacute;nez M, Acosta O, Hurtado H. </B>Nerve growth factor and neurotrophin-3 modulate the rabies virus infection of adult sensory neurons in primary cultures. Brain Res 2000;871:120-6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000072&pid=S0120-4157200400010001200012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>13. <B>Morimoto K, Hooper C, Carbaugh H, Fang-Fu Z, Koprowski H, Dietzchold B. </B>Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci USA 1998;95:3152-6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000073&pid=S0120-4157200400010001200013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>14. <B>Casta&ntilde;eda-Castellanos D, Castellanos JE, Hurtado H. </B>Differential use of the nicotinic receptor by rabies virus upon substrate origin. J Neurovirol 2002;8:150-4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000074&pid=S0120-4157200400010001200014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>15. <B>Mart&iacute;nez M, Ram&iacute;rez R, Hurtado H, Cepeda E, Avellaneda M, Benito M, Castellanos JE. </B>Effect of nicotinic agonist chronic exposure on adult mouse normal and rabies virus infected spinal ganglia culture. J Neurovirol 2002;8(S1):109-10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000075&pid=S0120-4157200400010001200015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>16. <B>Qi Y, Wang JK, McMillian M, Chikaraishi DM. </B>Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 1997;17:1217-25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000076&pid=S0120-4157200400010001200016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>17. <B>Suri C, Fung BP, Tischler AS, Chikaraishi DM. </B>Catecholaminergic cell lines from an adrenal glands of tyrosine hydroxilase SV40 T antigenic mice. J Neurosci 1993;13:1280-91.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000077&pid=S0120-4157200400010001200017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>18. <B>Lazaroff M, Dunlap K, Chikaraishi DM</B>. A CNS catecholaminergic cell line expresses voltage-gated currents. J Membr Biol 1996;151:279-91.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000078&pid=S0120-4157200400010001200018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>19. <B>Casta&ntilde;eda-Castellanos DR, Cano M, Wang JA, Cornbett A, Benson DD, Blanck T, Thornhill B, Recio-Pinto E. </B>CNS voltage-dependent Na+ channel expression and distribution in an undifferentiated and differentiated CNS cell line. Brain Res 2000;866:281-5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000079&pid=S0120-4157200400010001200019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>20. <B>Horton CD, Qi Y, Chikaraishi D, Wang JK. </B>Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J Neurochem 2001;76:201-9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000080&pid=S0120-4157200400010001200020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>21. <B>Hemachudha T, Laothamatas J, Rupprecht C. </B>Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002;1:101-9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000081&pid=S0120-4157200400010001200021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>22. <B>World Health Organization. </B>Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. URL: </FONT><A HREF="http://www.who.int/emc-documents/rabies/docs/whoemczoo966.pdf">http://www.who.int/emc-documents/rabies/docs/whoemczoo966.pdf</A><FONT FACE="Arial,Arial">; 2002.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S0120-4157200400010001200022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>23. <B>Mart&iacute;nez-Guti&eacute;rrez M, Aponte S, Recio-Pinto E, Castellanos J. </B>Neurotrophin inhibition of rabies virus infection in a central system neuron line (CAD-R1). J Neurovirol 2003;9-S3:124.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000083&pid=S0120-4157200400010001200023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>24. <B>Dietzschold B, Schnell M. </B>New approaches to the development of live attenuated rabies vaccines. Hybrid Hybridomics 2002;21:129-34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000084&pid=S0120-4157200400010001200024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>25. <B>World Health Organization. </B>World survey for rabies No.35 for the year 1999. WHO/CDS/CSR/EPH/2002. Geneva: World Health Organization; 2002.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000085&pid=S0120-4157200400010001200025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>26. <B>Jackson AC, Warrel MJ, Rupprecht C, Ertl HC, Dietzchold B, O’Reilly M, Leach RP, Fu Z, Wunner W, Bleck TP, Wilde H. </B>Management of rabies in humans. Clin Infect Dis 2003;36:60-3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000086&pid=S0120-4157200400010001200026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P>27. <B>Kallel H, Jouini A, Majoul S, Rourou S. </B>Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. J Biotechnol 2002;95:195-204</FONT><FONT FACE="Arial,Arial" SIZE=1>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000087&pid=S0120-4157200400010001200027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rupprecht]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hanlon]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Hemachudha]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rabies re-examined]]></article-title>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2002</year>
<volume>2</volume>
<page-range>327-43</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Receptores para virus de rabia]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2001</year>
<volume>21</volume>
<page-range>389-401</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schweighardt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Atwood]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Virus receptors in the human central nervous system]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2001</year>
<volume>7</volume>
<page-range>187-95</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lentz]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Burrage]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Crick]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tignor]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Is the acetylcholine receptor a rabies virus receptor?]]></article-title>
<source><![CDATA[Science]]></source>
<year>1982</year>
<volume>215</volume>
<page-range>182-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thoulouze]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Lafage]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Schachner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hartmann]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Cremer]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lafon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The neural cell adhesion molecule is a receptor for rabies virus]]></article-title>
<source><![CDATA[J Virol]]></source>
<year>1998</year>
<volume>72</volume>
<page-range>7181-90</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tuffereau]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Benejean]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Blondel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kieffer]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Flammand]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Low-affinity nerve growth factor receptor (p75NTR) can serve as a receptor for rabies virus]]></article-title>
<source><![CDATA[EMBO J]]></source>
<year>1998</year>
<volume>17</volume>
<page-range>7250-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Velandia]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rabies virus infection of cultured adult mouse dorsal root ganglion neurons]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>1996</year>
<volume>91</volume>
<page-range>621-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ray]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Power]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Ewalt]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Lodmell]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rabies viruses infect primary cultures of murine, feline, and human microglia and astrocytes]]></article-title>
<source><![CDATA[Arch Virol]]></source>
<year>1997</year>
<volume>142</volume>
<page-range>1011-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guigoni]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coulon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rabies virus is not cytolytic for rat spinal motoneurons in vitro]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2002</year>
<volume>8</volume>
<page-range>306- 17</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Morphometric analysis of McCoy cells inoculated with cerebrospinal fluid from patients with rabies]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>1998</year>
<volume>93</volume>
<page-range>509-14</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kissi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Badrane]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Audry]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lavenu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tordo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Brahimi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bourhy]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Dynamics of rabies virus quasispecies during serial passages in heterologous hosts]]></article-title>
<source><![CDATA[J Gen Virol]]></source>
<year>1999</year>
<volume>80</volume>
<page-range>2041-50</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Nerve growth factor and neurotrophin-3 modulate the rabies virus infection of adult sensory neurons in primary cultures]]></article-title>
<source><![CDATA[Brain Res]]></source>
<year>2000</year>
<volume>871</volume>
<page-range>120-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morimoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hooper]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carbaugh]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Fang-Fu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Koprowski]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dietzchold]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rabies virus quasispecies: implications for pathogenesis]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1998</year>
<volume>95</volume>
<page-range>3152-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda-Castellanos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differential use of the nicotinic receptor by rabies virus upon substrate origin]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2002</year>
<volume>8</volume>
<page-range>150-4</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Cepeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Avellaneda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Benito]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effect of nicotinic agonist chronic exposure on adult mouse normal and rabies virus infected spinal ganglia culture]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2002</year>
<volume>8</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>109-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[McMillian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chikaraishi]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>1997</year>
<volume>17</volume>
<page-range>1217-25</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fung]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Tischler]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Chikaraishi]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Catecholaminergic cell lines from an adrenal glands of tyrosine hydroxilase SV40 T antigenic mice.]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>1993</year>
<volume>13</volume>
<page-range>1280-91</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazaroff]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dunlap]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chikaraishi]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A CNS catecholaminergic cell line expresses voltage-gated currents.]]></article-title>
<source><![CDATA[J Membr Biol]]></source>
<year>1996</year>
<volume>151</volume>
<page-range>279-91</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda-Castellanos]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cornbett]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Benson]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Blanck]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Thornhill]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Recio-Pinto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[CNS voltage-dependent Na+ channel expression and distribution in an undifferentiated and differentiated CNS cell line]]></article-title>
<source><![CDATA[Brain Res]]></source>
<year>2000</year>
<volume>866</volume>
<page-range>281-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horton]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Qi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chikaraishi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[JK.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line]]></article-title>
<source><![CDATA[J Neurochem]]></source>
<year>2001</year>
<volume>76</volume>
<page-range>201-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemachudha]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Laothamatas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rupprecht]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges.]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2002</year>
<volume>1</volume>
<page-range>101-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies.]]></source>
<year>2002</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Gutiérrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aponte]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Recio-Pinto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neurotrophin inhibition of rabies virus infection in a central system neuron line (CAD-R1]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2003</year>
<volume>9-S3</volume>
<page-range>124</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dietzschold]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schnell]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[New approaches to the development of live attenuated rabies vaccines.]]></article-title>
<source><![CDATA[Hybrid Hybridomics]]></source>
<year>2002</year>
<volume>21</volume>
<page-range>129-34</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[World survey for rabies No.35 for the year 1999]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Warrel]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rupprecht]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ertl]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Dietzchold]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[O’Reilly]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leach]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Wunner]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bleck]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Wilde]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Management of rabies in humans]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2003</year>
<volume>36</volume>
<page-range>60-3</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kallel]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jouini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Majoul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rourou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells]]></article-title>
<source><![CDATA[J Biotechnol]]></source>
<year>2002</year>
<volume>95</volume>
<page-range>195-204</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
